Skip to Main Content

Author Details

Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
2004
54
21
PMIDPaper TitleJournal TitlePublished Year
34896200Retrospective evaluation of the symptom-based work restriction strategy of healthcare providers in the first epidemic of COVID-19 at a tertiary care hospital in Tokyo, Japan.Am J Infect Control2022
34859286Successful diagnosis of veno-occlusive disease caused by inotuzumab ozogamicin through minimal-invasive angiography: a case report.Ann Hematol2022
35210567VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells.Nat Cell Biol2022
34896200Retrospective evaluation of the symptom-based work restriction strategy of healthcare providers in the first epidemic of COVID-19 at a tertiary care hospital in Tokyo, Japan.Am J Infect Control2022
34859286Successful diagnosis of veno-occlusive disease caused by inotuzumab ozogamicin through minimal-invasive angiography: a case report.Ann Hematol2022
35210567VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells.Nat Cell Biol2022
32921688Celiac Disease Complicated by Rhabdomyolysis.Intern Med2021
33947846MAEA is an E3 ubiquitin ligase promoting autophagy and maintenance of haematopoietic stem cells.Nat Commun2021
33814498Three Cases of Esophageal Cancer Related to Fanconi Anemia.Intern Med2021
32921688Celiac Disease Complicated by Rhabdomyolysis.Intern Med2021
33076723Hemoglobin and C-reactive protein levels as predictive factors for long-term successful glucocorticoid treatment for multicentric Castleman's disease.Leuk Lymphoma2021
34798065CD62L expression level determines the cell fate of myeloid progenitors.Stem Cell Reports2021
34587247Efficient production of human neutrophils from iPSCs that prevent murine lethal infection with immune cell recruitment.Blood2021
33814498Three Cases of Esophageal Cancer Related to Fanconi Anemia.Intern Med2021
34587247Efficient production of human neutrophils from iPSCs that prevent murine lethal infection with immune cell recruitment.Blood2021
34798065CD62L expression level determines the cell fate of myeloid progenitors.Stem Cell Reports2021
33947846MAEA is an E3 ubiquitin ligase promoting autophagy and maintenance of haematopoietic stem cells.Nat Commun2021
33076723Hemoglobin and C-reactive protein levels as predictive factors for long-term successful glucocorticoid treatment for multicentric Castleman's disease.Leuk Lymphoma2021
32413329Snai2 Maintains Bone Marrow Niche Cells by Repressing Osteopontin Expression.Dev Cell2020
32413329Snai2 Maintains Bone Marrow Niche Cells by Repressing Osteopontin Expression.Dev Cell2020
30903101Author Correction: Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche.Nat Med2019
30963522A Case of Mesentero-axial Type of Acute Gastric Volvulus Successfully Reduced by a Balloon-assisted Endoscopy.Tokai J Exp Clin Med2019
30903101Author Correction: Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche.Nat Med2019
30988422Engineering a haematopoietic stem cell niche by revitalizing mesenchymal stromal cells.Nat Cell Biol2019
30988422Engineering a haematopoietic stem cell niche by revitalizing mesenchymal stromal cells.Nat Cell Biol2019
30963522A Case of Mesentero-axial Type of Acute Gastric Volvulus Successfully Reduced by a Balloon-assisted Endoscopy.Tokai J Exp Clin Med2019
29736022Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche.Nat Med2018
30314756The Majority of CD45<sup>-</sup> Ter119<sup>-</sup> CD31<sup>-</sup> Bone Marrow Cell Fraction Is of Hematopoietic Origin and Contains Erythroid and Lymphoid Progenitors.Immunity2018
29934585Stem cell factor is selectively secreted by arterial endothelial cells in bone marrow.Nat Commun2018
30191546A Case-control Study on the Risk Factors for Ischemic Colitis.Tokai J Exp Clin Med2018
29736022Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche.Nat Med2018
30191546A Case-control Study on the Risk Factors for Ischemic Colitis.Tokai J Exp Clin Med2018
29934585Stem cell factor is selectively secreted by arterial endothelial cells in bone marrow.Nat Commun2018
30314756The Majority of CD45<sup>-</sup> Ter119<sup>-</sup> CD31<sup>-</sup> Bone Marrow Cell Fraction Is of Hematopoietic Origin and Contains Erythroid and Lymphoid Progenitors.Immunity2018
28850106FANTOM5 CAGE profiles of human and mouse samples.Sci Data2017
28850106FANTOM5 CAGE profiles of human and mouse samples.Sci Data2017
29051371Adrenergic nerves activate an angio-metabolic switch in prostate cancer.Science2017
29051371Adrenergic nerves activate an angio-metabolic switch in prostate cancer.Science2017
27904106Fatal Hemorrhagic Gastrointestinal Angioectasia after Bone Marrow Transplantation for Dyskeratosis Congenita.Intern Med2016
26590301Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD).J Biochem2016
26634440Fetal liver hematopoietic stem cell niches associate with portal vessels.Science2016
27904106Fatal Hemorrhagic Gastrointestinal Angioectasia after Bone Marrow Transplantation for Dyskeratosis Congenita.Intern Med2016
26634440Fetal liver hematopoietic stem cell niches associate with portal vessels.Science2016
26590301Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD).J Biochem2016
25534203A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.Exp Hematol2015
25534203A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.Exp Hematol2015
24221694Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis.J Gastroenterol2014
25504228The molecular basis of myeloid malignancies.Proc Jpn Acad Ser B Phys Biol Sci2014
25669026[Cross-reactivity evaluation of improved estradiol (E2) assay reagent based on chemiluminescent enzyme immunoassay].Rinsho Byori2014
25297732[Molecular basis of hematological malignancies].Rinsho Ketsueki2014
  • 1 - 50 of 108

Recommended Authors

Zhijie Wu
and Blood Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 0
Yang Chen
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Nan Zhu
Shanghai General Hospital, Shanghai Jiaotong University
Career Start Year 2007
Number of shared co-authors 0
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 0
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 1
Christopher R Cogle
College of Medicine, University of Florida
Career Start Year 2003
Number of shared co-authors 0
Robert S Welner
University of Alabama at Birmingham
Career Start Year 2002
Number of shared co-authors 0
Sergei Doulatov
University of Washington
Career Start Year 2002
Number of shared co-authors 1
Phillip M Clair
Huntsman Cancer Institute, The University of Utah
Career Start Year 2001
Number of shared co-authors 0
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 1
Jalila Chagraoui
Institute for Research in Immunology and Cancer, University of Montreal
Career Start Year 2000
Number of shared co-authors 0
Peter Kurre
Children's Hospital of Philadelphia
Career Start Year 1999
Number of shared co-authors 1
Shinichiro Takahashi
Tohoku Medical and Pharmaceutical University Hospital.
Career Start Year 1998
Number of shared co-authors 1
Angela G Fleischman
University of California Irvine
Career Start Year 1998
Number of shared co-authors 0
Ravindra Majeti
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Yaowalak U-Pratya
Faculty of Medicine Siriraj Hospital, Mahidol University
Career Start Year 1998
Number of shared co-authors 0
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Yongjin Li
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 0
Arnaud Jacquel
Universite Cote d'Azur, INSERM U5
Career Start Year 1995
Number of shared co-authors 0
Ravi Bhatia
University of Alabama at Birmingham
Career Start Year 1992
Number of shared co-authors 0
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 0
Jose A Cancelas
Cincinnati Children's Hospital Medical Center
Career Start Year 1990
Number of shared co-authors 2
Guy Sauvageau
Universite de Montreal
Career Start Year 1988
Number of shared co-authors 0
Clayton A Smith
University of Colorado, Aurora CO.
Career Start Year 1987
Number of shared co-authors 0
George Q Daley
Boston Children's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 4
Daniel C Link
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 0
Hiromitsu Nakauchi
Advanced Research Institute, Tokyo Medical and Dental University
Career Start Year 1981
Number of shared co-authors 54
Stefan Burdach
Technische Universitat Munchen
Career Start Year 1981
Number of shared co-authors 0
John E Dick
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1980
Number of shared co-authors 0
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Career Start Year 1976
Number of shared co-authors 1

Collaborators

Toshio Kitamura
The University of Tokyo.
Co-authored papers 21
Paul S Frenette
Co-authored papers 10
Qiaozhi Wei
Co-authored papers 7
Maria Maryanovich
Co-authored papers 6
Sandra Pinho
Co-authored papers 6
Seishi Ogawa
Kyoto University
Co-authored papers 4
Halley Pierce
Co-authored papers 4
Ali H Zahalka
Co-authored papers 4
Jessica C Mar
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Co-authored papers 4
Chunliang Xu
Co-authored papers 4
Paul Ciero
Co-authored papers 3
Noboru Asada
Co-authored papers 3
Philip E Boulais
Co-authored papers 3
Tony J Kenna
Queensland University of Technology
Co-authored papers 2
Haruhiko Koseki
RIKEN Research Center for Allergy and Immunology
Co-authored papers 2
Stefano Gustincich
Istituto Italiano di Tecnologia
Co-authored papers 2
Cristian D Cruz
Co-authored papers 2
Yuki I Kawamura
Research Institute, National Center for Global Health and Medicine
Co-authored papers 2
Reto Guler
International Centre for Genetic Engineering and Biotechnology
Co-authored papers 2
Albert S B Edge
Harvard Medical School
Co-authored papers 2
Christophe Simon
RIKEN Yokohama Institute
Co-authored papers 2
Peter Heutink
German Center for Neurodegenerative Diseases (DZNE).
Co-authored papers 2
Ernst J Wolvetang
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Co-authored papers 2
Suzana Savvi
South African Medical Research Council (SAMRC), University of Cape Town
Co-authored papers 2
Soichi Ogishima
Tohoku University Graduate School of Medicine
Co-authored papers 2
Christine L Mummery
Leiden University Medical Center
Co-authored papers 2
Weonju Lee
Kyungpook National University, Kyungpook National University Hospital
Co-authored papers 2
Yohei Yonekura
RIKEN Center for Developmental Biology
Co-authored papers 2
Carsten O Daub
International Institute of Molecular and Cell Biology in Warsaw
Co-authored papers 2
Noriko Ninomiya
Japan Tobacco Inc.
Co-authored papers 2
Release 1.2